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Abstract: Idiopathic intracranial hypertension – IIH (synonymous old terms: benign 
intracranial hypertension - BIH, pseudotumor-cerebri - PTC) it’s a syndrome, related to 
elevated intracranial pressure, of unknown cause, sometimes cerebral emergency, 
occuring in all age groups, especially in children and young obese womans, in the absence 
of an underlying expansive intracranial lesion, despite extensive investigations. Although 
initial symptoms can resolve, IIH displays a high risk of recurrence several months or 
years later, even if initial symptoms resolved. Results: A 20-year-old male, obese since 
two years (body mass index 30, 9), was admitted for three months intense headache, 
vomiting, diplopia, progressive visual acuity loss. Neurologic examination confirmed 
diplopia by left abducens nerve palsy, papilledema right > left. At admission, cerebral CT 
scan and cerebral MRI with angio MRI 3DTOF and 2D venous TOF was normal. Despite 
treatment with acetazolamide (Diamox), corticosteroid, antidepressants (Amitriptyline), 
anticonvulsivants (Topiramate) three weeks later headache, diplopia persist and vision 
become worse, confirmed by visual field assessment, visual evoked potential (VEP). A 
cerebral arteriography demonstrate filling defect of the superior sagittal sinus in the 1/3 
proximal part and very week filling of the transverse right sinus on venous time. 
Trombophylic profile has revealed a heterozygote V factor Leyden mutation, a 
homozygote MTHFR and PAI mutation justifying an anticoagulant treatment initiated 
to the patient. The MRI showed a superior sagittal sinus, right transverse and sigmoid 
sinus thrombosis, dilatation and buckling of the optic nerve sheaths with increased 
perineural fluid especially retrobulbar, discrete flattening of the posterior segment of the 
eyeballs, spinal MRI showed posterior epidural space with dilated venous branches, with 
mass effect on the spinal cord, that occurs pushed anterior on sagittal T1/T2 sequences 
cervical and thoracic. The opening pression of lumbar puncture, done with the patient 
in the lateral decubitus position, was 60 cm H2O, the cytochemical CSF study were 
normal. The patient was operated: a lombo-peritoneal with a variable pressure valve was 
inserted. Two months after the patient general condition improved: he was without 
headache, abducens palsy and the visual field assessment, ocular motility examination, 
ophthalmoscopy were normal. Conclusion: IHH is rare, variable in evolution, and in 
many cases it disappears on its own within 6 months without affecting life expectancy. 
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Weight loss, fluid or salt restriction, in conjunction with medical treatment, angioplasty 
and venous stenting across the sinus stenosis under general anesthesia and surgical 
treatment (shunting, optic nerve sheath decompression and fenestration, gastric by-pass 
surgery) are treatment alternatives. Such disorder should be closed monitored because 
10 to 25% of cases could be affected by recurrencies or by permanent vision loss to those 
patients with resistant papilledema despite treatment. 
Key words: idiopathic intracranial hypertension-IIH, benign intracranial hypertension - 
BIH, pseudotumor-cerebri – PTC, superior sagittal and transverse sinus thrombosis, 
intracranial pressure, visual evoked potential (VEP) 
 
Introduction 
Idiopathic intracranial hypertension – IIH 
(synonymous old terms: benign intracranial 
hypertension - BIH, pseudotumor-cerebri - 
PTC) it’s a syndrome, related to elevated 
intracranial pressure of unknown cause, 
sometimes cerebral emergency, occurring in 
all age groups, especially in children and 
young obese womans, with several symptoms 
includind visual loss; without underlying 
expansive intracranial lesion, hydrocephalus, 
dural sinus thrombosis; with a recurrency 
potential months or even years later, even if 
initial symptoms resolved. (1-12) 
Case report 
A 20-year-old male, obese since two years 
(body mass index 30,9), was admitted june 
2015 in a neurology department for three 
months intense headache, vomiting, diplopia, 
progressive visual acuity loss. From his 
medical records we noticed: left otomastoiditis 
since childhood, a car accident with cranio-
cerebral trauma in 2007 with a 3 mm 
nonoperated left subdural haematoma and 
epicranian haematoma. Clinical examination 
revealed good clinical condition, without 
motor or sensitive deficits, orientated, no 
ataxy, ocular motility examination diplopia by 
left abducens nerve palsy, visual function tests: 
both eyes 2/3 without corrections, visual field 
assessment is normal with light colour 
desaturation for red and green, 
ophthalmoscopy: papilledema right > left, with 
peripapillary flame hemorrhages, venous 
engorgement. Angiofluoroscopy: arteriolar 
filling at 11 seconds, papillar leakage of 
contrast substance, both papilla becomes 
hyperflorescent on late exposures, dilated 
vessels. The study of visual evoked potentials 
(VEP) has shown on the right eye latency of 
P100 wave 145 ms (normal value = 110 ms) 
and amplitude of 71mV (normal value > 5μV). 
To the left eye, the latency of P100 wave was 
121 ms, amplitude of 58 mV. 
An immunologic screening demonstrate 
CRP positive, ANA positive, Ac anti DNA dc, 
Ac anti SM, Ac anti Ro, Ac anti La, 
cANCA,pANCA, Ac anti U1RNP, Ac anti 
GP1beta. An infectious screening was negative 
for Ac anti HIV, Ac anti HCV, Ag HBS, Ac 
anti CMV, Ac anti EBV, Ac anti HSV, Ac anti 
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Borrelia, Ac anti Mycoplasma, Ac anti 
Chlamydia, Ac anti Toxoplasma. TheRIA-
screening for TSH, FSH, LH, PRL and GH 
found normal levels. 
At admission, cerebral CT scan was nomal 
(Figure 1). Cerebral MRI with angio MRI 
3DTOF and 2D venous TOF showed: supra 
and infratentorial structures with normal 
morphology and normal MRI signal, no acute 
cerebral lesions visible in diffusion. On T2 EG 
sequence no hemorrhages supra or 
infratentorial, ventricular system with normal 
dimensions, shapes, topography. Selar and 
paraselar region, orbital region and optic 
nerves with normal MRI signal, no vascular 
malformations, nomal dural sinuses. 
 
 
A 
 
B 
Figure 1 - Normal cerebral CT scan at admission: 
A axial section, B sagittal section 
 
The patient was put on a low calories diet, 
corticosteroid therapy was initiated and 
consisted of a bolus methypredisolone - 1g/d 
for 5 days, followed by an oral corticosteroid 
dose decreasing over three weeks), associated 
with acetazolamide (Diamox 1g/d), 
antidepressant (Amitriptyline), 
anticonvulsivant (Topiramate). 
Three weeks later headache, diplopia 
persist and vision become worse (1/10 on the 
right side and 3/10 on the leftside). A cerebral 
arteriography demonstrate normal 
arteriography on right side - arterial time; 
filling defect of the superior sagittal sinus in 
the 1/3 proximal part and very week filling of 
the transverse right sinus on venous time. On 
the left side cerebral angiography was normal 
(Figure 2) 
The opening pression of lumbar puncture, 
done with the patient in the lateral decubitus 
position, was 60 cm H2O, the cytochemical 
CSF study were normal (protein 
concentration: 0.23 g/ l, CSF glucose: 0.42 g/ l 
and 3 white cell /mm³). 
 
 
A 
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B 
 
C 
Figure 2 - Cerebral arteriography revealing venous 
filling defect of the superior sagittal sinus in the 1/3 
proximal part (A&B sagittal view, C coronal view) 
 
Trombophylic profile has revealed a 
heterozygote V factor Leyden mutation, a 
homozygote MTHFR and PAI mutation 
justifying an anticoagulant treatment initiated 
to the patient. 
A new cerebral and spinal MRI revealed 
(Figure 3): 
 
A 
 
B 
 
C 
 
D 
Figure 3 - Cerebral MRI 
A coronal cerebral MRI (FLAIR): venous sinuses with 
gracile lumen 
B&C detail: cerebral MRI (axial STIR): dilatation and 
buckling of the optic nerve sheaths with increased 
  
 
 
 
Romanian Neurosurgery (2015) XXIX 4: 385 - 396         389 
DOI: 10.1515/romneu-2015-0054 
 
 
 
 
 
 
perineural fluid especially retrobulbar, discrete 
flattening of the posterior segment of the eyeballs  
D: cerebral MRI (TOF sequence) confirming filling 
defect of the 1/3 anterior part of the   superior sagittal 
sinus (SSS) 
 
  
E                                         F 
  
G                                         H 
Figure 3 - Spinal MRI 
EFGH: spinal MRI showed posterior epidural space 
with dilated venous branches, with mass effect on the 
spinal cord, that occurs pushed anterior on sagittal 
T1/T2 sequences cervico-thoracal and thoracic 
(arrows) 
A week after, headache increased and the 
patient was transferred and operated to the 
Neurosurgery Department. A lombo-
peritoneal shunt with a variable pressure 
Medtronic valve was performed. At operation 
the opening pression of lumbar puncture, 
done with the patient in the lateral decubitus 
position was 85 cm H2O. Two months after, 
the patient general condition improved: he 
was without headache, abducens palsy and the 
visual field assessment, ocular motility 
examination, ophthalmoscopy, visual evoked 
potentials were normal. 
The peculiarity of this case lies in the 
progressive emergence of a severe idiopathic 
intracranial hypertension syndrome at a 
young male, age of 20 years, obese - recently 
instaled, not leated to a endocranial cause, 
with normal hormonal tests, to which 
trombophylic profile has revealed a 
heterozygote V factor Leyden mutation, a 
homozygote MTHFR and PAI mutation; also 
the opening pression of lumbar puncture, 
done with the patient in the lateral decubitus 
position, was initial 60 cm H2O and at 
operation 85 cm H2O. The medical treatment 
failed, but lombo-peritoneal shunt with a 
variable pressure Medtronic valve was 
beneficial. 
Discussion 
Idiopathic intracranial hypertension – IIH 
occurs in about 1-2 per 100,000 people, each 
year, with severe visual loss in 10-30% of 
patients, at a median age of 20-45 years and 
affects women four to nine times more 
frequent than men (6, 12, 13). In young obese 
women, the incidence of IIH has been shown 
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to reach 20 cases per 100,000 (1, 2, 13, 14). 
Although this condition has no genetic or 
ethnic predilection, studies have shown a 
higher prevalence of IIH in overweight and 
obese people (1, 2, 15). 
Historical considerations (10, 11, 16, 17) 
1893 Quincke Heinrich (18) is credited 
with the first report of IIH, wrong referring to 
serous meningitis 
1904 Nonne Max (19) introduced the term 
"pseudo-tumor-cerebri" to define those 
patients in whom no tumour was found, but a 
disease mimicking a brain tumor was 
described 
1937 Dandy Walter (20) identified the 
diagnostic criteria for IIH and introduced 
subtemporal decompressive surgery in the 
treatment of this disease 
1949 ventriculo-peritoneal shunts were 
first used and were later replaced in 1971 by 
lombo-peritoneal shunts, with better results 
1954 Sir Charles Symonds (21) suggested 
middle ear infection as a cause of venous sinus 
thrombosis and otitic hydrocephalus 
1955 same condition was renamed "benign 
intracranial hypertension" by Foley, cited by 
(11) 
1969 Buchheit, cited by (16), introduced 
the term idiopathic intracranial hypertension, 
replacing the term ‘benign intracranial 
hypertension’, abandoned due to visual 
disturbances. 
1989 the terminology of this disease was 
revised to "idiopathic (of no identifiable cause) 
intracranial hypertension"  
1988-1993 optic nerve fenestrations – first 
described in 1871 were made after negative 
reports on shunting in the 1980s 
Several conditions have been associated with 
IIH (2, 3, 5, 10, 11, 15, 22) 
- obesity: obese women of childbearing age 
are more likely to the disorder due to elevate 
intraabdominal pressure, venous and even 
intracranial venous pressure. In our case 
obesity was recently instaled, not leated to a 
endocranial cause, with normal hormonal 
tests.  
- onset of menstruation (menarche) 
- pregnancy - at any stage 
- medications (no fully clarified causal 
relation with this disorder) including: high-
dose vitamin A > 100,000 U/day - see 
isotretinoin for acne, long-term 
antibiotherapy with penicillin, cyclosporine, 
minocycline, tetracycline, nalidixic acid, 
nitrofurantoin, carbidopa, levodopa, 
indomethacin, ketoprofen, corticosteroids - 
topical and systemic, phenytoin, growth 
hormone, oral contraceptives, tamoxifen, 
lithium and anabolic steroids 
- diseases such as: Addison, Cushing’s, 
Behcet's (23), polycystic ovary syndrome, 
systemic lupus erythematosus, multiple 
sclerosis, herpetic encephalitis, Reye 
syndrome, sleep apnea, chronic kidney 
disease, chronic respiratory insufficiency, 
familial mediterranean fever or others 
disorders, such as iron deficiency, anemia, 
uremia, thrombocytopenic purpura, 
hypothyroidism, hypoparathyroidism, 
psittacosis, metabolic, toxic causes 
- disorders of cerebral venous drainage: 
secondary thrombosis due to coagulopathy, 
relative stenosis due to a venous flow anomaly 
or even extravascular tumors that may impare 
due absorption of CSF; increased venous red 
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blood cell (RBC) aggregation and relatively 
elevated fibrinogen concentrations. 
To explain the pathogenesis of IIH, starting 
from 4 evidences: a high rate of occurrence in 
obese women during the childbearing years, 
CSF outflow has reduced conductance, normal 
ventricular size, no hydrocephalus and no 
histologic evidence of cerebral edema, several 
theories have been advanced, generating 
pathological conditions acting simultaneously 
as follows: (1-3, 11, 13, 24-26) 
- the increased production of cerebrospinal 
fluid was the first hypothesis to be proposed, 
but later dismissed following experimental 
data (27) 
- the increased resistance to cerebrospinal 
fluid absorption (13, 24) 
- the increased blood flow to the brain or 
cerebral tissue was suggested using phase 
contrast MRA studies and biopsy samples. IIH 
is only an incomplete intracranial 
hypertension syndrome initial: increased 
intracranial pressure is very important, up to 
60–80 mmHg, but the brain vascular auto 
regulation compensates the increase in 
intracranial pressure and maintains cerebral 
blood flow (24) 
- restricted venous drainage, by narrowing 
or stenosis of two large sinuses in the brain low 
grade stenosis of the SSS and transverse sinus  
- a condition which could be an effect or a 
cause of IIH: raised intracranial pressure 
causes venous narrowing in the transverse 
sinuses, resulting in venous hypertension 
(raised venous pressure), with decreased 
cerebrospinal fluid resorption via arachnoid 
granulations and further lead to a rise of 
intracranial pressure and cerebral oedema (4, 
17, 28-33) 
- obesity increases intra-abdominal 
pressure, raises cardiac filling pressures and 
impedes venous return from the brain due to 
the valveless venous system that exists from 
the brain to the heart, with a subsequent 
elevation in intracranial venous pressure, 
chronic interruption of the axoplasmic flow of 
the optic nerves and ensuing papilledema as a 
consequence of this pressure, leading to 
irreversible optic neuropathy (2) 
IIH diagnosis (1, 3), is based on the criteria 
devised by Dandy in 1937 (20) and 
subsequently modified by: 
- Smith 1985 (34) replaced 
ventriculography with CT scan 
- Digre and Corbett 2001 (3) added the 
requirement that the patient is awake and 
alert, no other cause for the raised ICP is 
found, including exclusion of venous sinus 
thrombosis as an underlying cause 
- Friedman and Jacobson 2002 (35) MR 
venography is only required in atypical cases: 
men and woman  with normal weight age over 
44 years, prepubertal children. 
- the lumbar puncture should be 
performed with patient lying sideways 
Current diagnostic IIH criteria (1-3, 5, 15, 
29, 35, 36) require the following: 
1. signs and symptoms of intracranial 
hypertension syndrome 
- moderate to severe headaches in 92–94% 
of cases, revealing, progressive, starting 
retroorbital, worsening with eye movement, 
generalized in character and throbbing in 
nature, especially in the morning or during 
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physical activity; exacerbated by coughing and 
sneezing 
- radicular pain - uncommon symptom, 
usually in the neck and shoulders 
- nausea, vomiting 
- dizziness 
- pulsatile tinnitus in one or both ears (64–
87%), synchronous with the pulse (37) 
- visual disturbances (80 % of cases): 
blurred or distortion (metamorphopsia) of 
central vision - caused by macular wrinkling 
and subretinal fluid spreading from the 
swollen optic disc, often predominantly 
orthostatic, initially in the periphery, in the 
nasal inferior quadrant but progressively 
towards the center of vision; loss of color 
vision; visual obscurations affecting one or 
both eye – seconds lasting episodes or 
blindness in 30% of cases; photopsia - light 
flashes; sudden visual loss in 91% of cases due 
to ischemic optic neuropathy or a retinal 
vascular occlusion associated with the 
papilledema; diplopia by abducens paly uni or 
bilateral. Rarely, patients presenting with 
increased ICP with related optic nerve edema 
may be asymptomatic. Visual acuity is usually 
normal until significant peripheral visual field 
loss with progressive postpapilledema by optic 
atrophy has occurred (23). In children, 
numerous nonspecific signs and symptoms 
may be present: numbness of the extremities, 
generalized weakness, loss of smell and 
coordination; rarely third, fourth or even facial 
nerve nerve palsy uni or bilateral may appear 
(15, 35), papilledema in addition to subretinal 
hemorrhages are poor visual prognostic signs. 
Uncontrolled papilledema results in 
progressive peripheral visual field constriction 
or nerve fiber bundle defects (11). 
2. normal neurological examination 
excepting diplopia by abducens palsy, uni or 
bilateral 
3. the patient is awake and alert 
4. normal cranio-cerebral and spinal 
investigations (1-3, 36, 38-42) 
- CT with and without contrast, angio-CT 
venous time 
- emmergency MRI including the following 
sections: native in sagittal T1, axial: T2 flair, 
diffusion T2*;with contrast (Gadolinium)T1 
fat sat on orbits, axial cuts T1 on the brain; 
using axial and coronal sections 2 mm thick 
centered on orbits FSE T2 
- MR venography, a cerebral angio MRV 
with gadolinium and manometry to exclude 
the possibility of an intracranial mass, a 
cerebral venous sinus thrombosis, venous 
sinus stenosis/obstruction or a dural fistula, to 
explain physiopathology or even for 
therapeutic interest to implant a stent (4, 5, 15, 
32, 35). 
IIH commonly presents with: normal or 
small (slit-like) and symmetric lateral 
ventricles, tortuous optic nerves, dilatation 
and buckling of the optic nerve sheaths with 
increased perineural fluid (42), minimal 
flattening of the posterior segment of the 
eyeballs, bulging optic discs, possible 
moderate to severe smooth-walled venous 
stenosis affecting the longitudinal or 
transverse sinus; "empty sella sign" (flattening 
of the pituitary gland due to increased 
pressure) and enlargement of Meckel's caves 
(41). Occasionally: T2 signal intensity of the 
optic nerve, discreet ptosis of cerebellar tonsils 
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(40). Follow-up MRI or CT scans may be 
needed to rule out hidden cancer. 
5. increased opening pression of lumbar 
puncture, performed with the patient in the 
lateral decubitus position, CSF pressure > 25 
cmH2O with normal biochemical and 
cytological composition of CSF 
6. no other explanation for the raised 
intracranial pressure as metabolic, toxic or 
hormonal 
In addition to IIH diagnostic criteria the 
following investigations should be performed 
(1-3, 11, 15): 
Visual function tests, visual field 
assessment, ocular motility examination, 
ophthalmoscopy (funduscopy) are mandatory 
to diagnose and monitories patients with IIH. 
At ophthalmoscopy: papilledema is seen in 
95% of cases, without correlation with visual 
impairment severity, absent or unilateral 
especially in young children, sometimes 
bilateral, asymmetric; peripapillary flame 
hemorrhages, venous engorgement, hard 
exudates, telangiectatic vessels on the disc 
surface, optociliary shunt veins. Chronic 
papilledema is associated with optic disc 
pallor, Paton lines (arc-shaped retinal wrinkles 
concentric with disc margin) along the 
temporal side of inferior pole of disc. Late 
chronic optic atrophy can also be seen: 
decreased visual acuity with significant 
peripheral visual field loss especially in the 
inferior nasal quadrant of the visual field, 
diffuse pallor of disc and absence of small 
arterial vessels on surface are noted, with very 
little disc elevation. Disc margin in the upper 
and lower poles and nasal margin is obscured 
by some residual edema in nerve fiber layer 
and gliosis that often persists even after all 
edema has resolved. In general the impact of 
idiopathic HIC on visual function is usually 
appreciated by repeated studies of the visual 
field, also by altered visual evoked potential 
(VEP)  - see our case too (41). 
- blood tests to patients with IIH (1, 2, 5) 
are necessary for ruling out systemic lupus 
erythematosus, collagen-vascular diseases, to 
identify the procoagulant profile, etcetera. 
They include: complete blood count, 
erythrocyte sedimentation rate, serum iron, 
iron-binding capacity, full procoagulant 
profile regardless to those patients of previous 
history of thrombosis or MRI - including 
protein S, protein C, homocysteine levels, 
antithrombin III, factor V Leiden variant, 
antiphospholipid/anticardiolipin antibodies, 
lupus anticoagulant and platelet aggregation 
studies; also antinuclear antigen (ANA) profile 
(eg, anti-dsDNA and anti-ssDNA), Lyme 
screening test - enzyme-linked 
immunosorbent assay ELISA to those patients 
who have a history of exposure to Lyme in 
areas of endemic disease.  
- cerebrospinal fluid studies (2, 11) include 
the following: opening pressure, white blood 
cell and differential counts, red blood cell 
count, total protein, quantitative protein 
electrophoresis, glucose, bacterial culture and 
sensitivity, Cryptococcal antigen - especially in 
patients with HIV, Syphilis markers - eg, rapid 
plasma reagin- RPR, tumor markers and 
cytology (in patients with a history of cancer 
or with clinical features suggesting occult 
malignancy) 
IHH treatment goals are (2, 3, 15, 23, 31, 39, 
43, 44): the prevention of visual loss and 
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blindness, symptom control, weight loss, fluid 
or salt restriction.  
Medical treatment (1-3, 7, 43, 44) is based 
on: acetazolamide (Diamox) for six months - 
in conjunction with a low-sodium weight-
reduction diet modestly improved vision, 
reduced intracranial pressure, improved 
quality of life and reduced papilledema; 
furosemide; digoxin (reduces CSF production 
by as much as 78% in humans, probably by 
inhibiting the Na-K-ATPase pump); 
analgesics: primary headache prophylaxis with 
antidepressants (Amitriptyline), 
anticonvulsivants (Topiramate); 
corticosteroids – as in our case is usefull 
especially in patients with papilledema 
(reducing CSF production by as much as 78% 
in humans, probably by inhibiting the Na-K-
ATPase pump binder). Repeated lumbar 
punctions to control ICP should be abandoned 
due to questionable results and infectious risks 
(11). 
For patients with raised ICP due to severe 
transverse sinus stenosis, angioplasty and 
venous stenting across the stenosis, under 
general anesthesia, may improve CSF 
resorbtion, decrease and even cure IIH 
symptoms as well as papilloedema (28, 38, 45, 
46). 
Surgical treatment of IIH (1-3, 43) is 
recommended if: medical therapy proves 
unsuccessful or is not tolerated, vision 
deteriorate; as in our case. In the absence of 
randomized controlled trials, surgical 
treatment include: shunting – lombo-
peritoneal or ventriculo-peritoneal with 
ventricular cateter inserted stereotactically 
preferably with a variable pressure valve (42, 
47-51), optic nerve sheath decompression and 
fenestration (52, 53), gastric bypass surgery for 
obese patients (5). IIH may resolve after initial 
treatment, may go into spontaneous remission 
(although it can still relapse at a later stage) or 
may continue chronically (5, 35). 
Conclusion  
IHH is rare, variable in evolution, and in 
many cases it disappears on its own within 6 
months without affecting life expectancy (2). 
Weight loss, fluid or salt restriction, in 
conjunction with medical treatment, 
angioplasty and venous stenting across the 
sinus stenosis under general anesthesia and 
surgical treatment (shunting, optic nerve 
sheath decompression and fenestration, 
gastric by-pass surgery) are treatment 
alternatives. Therefore a long term follow up 
of these patients is essential to improve the 
prognosis, because 10 to 25% of cases (5, 23) 
could be affected by recurrencies or by 
permanent vision loss to those patients with 
resistant papilledema despite treatment. 
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